Skip to search formSkip to main contentSkip to account menu

anamorelin

A synthetic, orally bioavailable, small-molecule ghrelin mimetic with appetite-stimulating and anabolic activities. Anamorelin binds to and… 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

HydrazinesOligopeptides
anamorelin hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Palliative care: Anamorelin provides benefit to patients with cachexia
advanced-stage cancer, with no specific treatment approaches currently approved. Now, data from a phase II study involving… 
Review
2017
Review
2017
What is next after anamorelin?
Purpose of review In spite of its relevance, treatments for the cancer anorexia and cachexia syndrome (CACS) are not available… 
2016
2016
Targeting cancer cachexia: we're on the way.
2016
2016
Efficacy of anamorelin in cachectic patients with non-small cell lung cancer (NSCLC) and low BMI (< 20 kg/m2): Post-hoc analysis of two phase III studies.
203 Background: Patients with advanced cancer frequently experience anorexia/cachexia, which can be characterized by weight loss… 
2015
2015
Phase III trials of anamorelin in patients with advanced non-small cell lung cancer (NSCLC) and cachexia (ROMANA 1 and 2)
9500 Background: Patients with advanced cancers frequently experience anorexia and cachexia, which is associated with decreased… 
2015
2015
Anamorelin in patients with advanced non-small cell lung cancer and cachexia: Results from the phase III studies ROMANA 1 and 2.
175 Background: Cancer anorexia-cachexia syndrome is common in patients with non-small cell lung cancer (NSCLC). It is… 
2015
2015
A safety extension study of anamorelin in advanced non-small cell lung cancer patients with cachexia: ROMANA 3.
e20715 Background: Cancer anorexia-cachexia syndrome is a multifactorial condition, characterized by decreased body weight… 
Review
2013
Review
2013
Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology
Sarcopenia and cachexia are significant medical problems with a high disease-related burden in cardiovascular illness. Muscle… 
2013
2013
Phase III clinical trials with anamorelin HCl, a novel oral treatment for NSCLC cachexia.
TPS9649 Background: Cancer anorexia/cachexia is a debilitating and life-threatening complication of an underlying malignancy that… 
2011
2011
Regional Analysis of Gastric Emptying Scintigraphy Provides Better Correlation of Dyspeptic Symptoms With Abnormal Gastric Emptying
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)